Oxford BioDynamics (LON:OBD) Stock Price Down 12.1% – Here’s Why

Oxford BioDynamics Plc (LON:OBD)’s stock price fell 12.1% on Monday . The stock traded as low as GBX 0.54 ($0.01) and last traded at GBX 0.55 ($0.01). 5,719,300 shares changed hands during trading, an increase of 9% from the average session volume of 5,229,809 shares. The stock had previously closed at GBX 0.63 ($0.01).

Oxford BioDynamics Price Performance

The company has a current ratio of 0.68, a quick ratio of 2.80 and a debt-to-equity ratio of 370.22. The company has a 50 day moving average of GBX 1.07 and a 200-day moving average of GBX 3.13. The firm has a market capitalization of £1.73 million, a P/E ratio of -9.23 and a beta of 0.42.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.